✨ Upcoming event on MedNews Week, Mark your Calendars!✨
We are excited to be Shining the Spotlight on the work of Global Leader & Keynote Speaker, Dr. Marco Davila of Roswell Park Comprehensive Cancer Center as he discusses the Future of Cell & Gene Therapy.
Dr. Davila's accomplishments:
⚕️Invited to Present at United States Congress House Cancer Caucus Briefing: "Cancer Immunotherapies"
📷Senior Vice President & Associate Director of Translational Research
We’re excited to invite you to an exclusive keynote event with 👩🏻⚕️Dr. @DanielleHammo20 MD, FRCP(C), in the Department of Leukemia🩸@MDAndersonNews . Dive deep into how small cellular clones can lead to significant health outcomes!
🗓️ Date: Saturday, August 10
🕓 Time: 4:00 PM EST
In case you missed out on the Keynote talk on the🔬 topic; Precision Epigenetic Targeting for Germinal Center Lymphomas by @jenamengual, MD
Catch the replay at: https://t.co/8rX5PVUTTX
@OncLive@oncodaily@Columbia
Dr. Amengual's accomplishments:
🏆 Proud recipient of many awards, including:
Super Doctors - New York Times Honoree
Irving Scholar at the Irving Institute for Clinical and Translational Research
👩🏫 Passionate Educator & Leader
Associate Professor of Medicine at CUMC
I extend my heartfelt 🌟 congratulations💫🏅 to Dr. @YLeyfman on his recent inclusion in @marquiswhoswho, recognizing his expertise in healthcare, research, education, and development.
https://t.co/zJzREn5qEi
I am thrilled to share that for over a year, I have had the immense pleasure of being part of @MedNewsWeek. Dr. @YLeyfman's unwavering guidance and visionary leadership have been pivotal in my personal and professional growth.
Pancreatic cancer research is crucial as it’s predicted to become the second deadliest tumor.
Our review in @Cancers_MDPI, inspired by @MPishvaian of @JohnsHopkins, discusses the promise of personalized medicine in improving outcomes for this complex and fascinating disease.
We are honored to announce @MedNewsWeek participation at #ASCO24!
Thank you @ASCO@JCO_ASCO for the possibility to share our impact on enhancing equity and inclusivity in hematology-oncology education.
We're committed to making even more significant contributions in the future!